Gilead Sciences Usa Bangladesh covid-19 Government medicines patient Gilead Sciences Usa Bangladesh

Beximco Pharma launches first generic remdesivir for Covid-19

Reading now: 671
www.pharmaceutical-technology.com

Bangladesh-based generic pharmaceuticals manufacturer Beximco Pharmaceuticals has launched the first generic version of antiviral drug remdesivir, originally developed by Gilead Sciences.

Recently, Gilead secured emergency use authorisation from the US Food and Drug Administration (FDA) for remdesivir to treat Covid-19.

Beximco Pharmaceuticals is the first company in the world to introduce a generic of the drug, under the brand name Bemsivir, to treat the viral disease.

The launch comes after Bangladesh’s Directorate General of Drug Administration (DGDA) granted emergency use authorisation for Bemsivir IV injection today Emergency approvals could boost the use of the drug in hospitalised patients, primarily in developing and least

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA